Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
See Biotech Values #245275:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171071141
Exactly! The EOLS data is a total sham and it's not even new. It was already released earlier this year and discussed at length. It's unfortunate to see that @soma2022 and @boraborak38 are so easily fooled but that's exactly EOLS' game plan: confuse injectors. It's no match for Daxxify though and the patients will obviously see the difference themselves.
I'm not necessarily expecting formal guidance, but they obviously won't be able to avoid questions about the outlook in the Q&A.
If the outlook is positive there should be some mention in the press release and prepared statements on the call. If the Q&A is the first time we hear about Q4 and beyond that would be bearish.
Partly yes, of course. RVNC is far from the only stock in the toilet. RVNC fundamentals also contributed obviously to the multi-month selloff.
Today's move has nothing to do with RVNC fundamentals or any earnings leak. The U.S. 10 year Treasury yield is down about 5% after the FOMC meeting yesterday, which is driving long duration assets (like RVNC) higher.
I'm not bullish on Q3 earnings but the market will look past Q3 if the outlook for Q4 and beyond is strong.
As you said, social media is full of glowing reviews for Daxxify.
Volume has been pitiful—and nobody wants to step in to buy money losing small caps at any price with the fear over long bond yields. Clarity on the path of yields and/or Daxi sales growth could cause the stock to be repriced rapidly.
RVNCfan is not a shill but this is exactly why I've been making so much noise about the FUD campaign. FUD is effective! FUD doesn't have to convince you to be effective, it just has to spark doubt and make you uncertain.
Don't be naïve @marthambles. Do you really believe this particular review is honest? This review doesn't even attempt to hide its bias and is pathetic. There are other more credible negative reviews out there than this farce.
This one is clearly a shill (ABBV or otherwise) "review."
The leading of the patient and her facial expressions are instantly discrediting and ridiculous.
I think jbog was suggesting that NVO and LLY will be so flush with cash that they can dominate R&D and M&A—and/or that nearly all future healthcare spending will be allocated to GLP-1. It sounds silly but jbog's take is essentially the market's view. It's analogous to what's been happening in tech with NVDA. If you're buying NVO or LLY at these prices you better hope none of the potential safety problems turn out to be a significant issue—and that everybody everywhere ends up on a GLP-1 forever. This is the clown show I spoke of previously—the market is over-extrapolating, imo, the overall impact of these drugs. The total pharma pie will continue to grow and is large enough for many players.
That's interesting and not what I was expecting. Thanks for your reply.
@Emannow can you confirm this rumor that Taryn Conway has left RVNC?
Thanks. "Analysis" belongs in quotes. They backed into the "analysis" from their PT.
EOLS share price is irrelevant, however we are not that far off from EOLS' enterprise value at this point, which does show how much of a clown show this has become. This is what capitulation looks like—people simply don't want to own this stock at any price. RVNC shot themselves in the foot somewhat by preannouncing in Q1 of this year—now the lack of a preannouncement is tantamount to saying the results are bad. Q3 sales were likely down from Q2. The situation with bond yields is also weighing heavily on all small caps and money losing companies.
Foley needs to be exited. Not because of the collapse in the stock price per se, but because of his profligate spending and tone-deaf response to the annihilation of shareholder value.
I previously defended Foley and felt he was unfairly blamed for problems that were left over from the Dan Browne days. That may or may not be true—Dan Browne certainly made plenty of mistakes—but at this point I think most people here would rather have Dan back vs Mark.
You heard it here first folks. The latest bullish sequela from the Ozempic craze: airline stocks!
😆🙃😉
My reply was about the broader overreaction to GLP-1 drugs.
There will obviously be real impacts—some very significant. I have no knowledge or interest in dialysis companies so I can't speak to that specifically.
As Dew mentioned, the clown show is the over extrapolation of the data, not the data itself—as well as the herd mentality exhibited by most fund managers. Peloton stock was up today on this news.
It's gotten a bit ridiculous that every new data point about GLP-1 causes this kind of overreaction. We know that GLP-1 drugs cause people to lose weight and being overweight has broad implications.
Given the above there's really an endless number of successful studies you could run with these drugs. How about a study to determine if Ozempic improves this guy's mile time. Buy NKE?
That's definitely one of the factors weighing on the stock today. However, Morgan Stanley sell-side analysis is worse than worthless. They also happen to be shills for ABBV.
Their PT update is also meaningless because they obviously can't have a hold rating on a stock and a PT 2.5x the current price. There's no actual new research from them as far as I'm aware.
It's a clown show. Reminds me of when Zoom video became a $150B company because "vid chat."
The market loves stories and right now the story is that being overweight is so 2010's.
It's obvious that being overweight impacts just about every health metric. I'm not sure how many more of these studies NVO and LLY can parade around before the market tires of the same story being repackaged over and over.
Don't forget the impact to food stocks like PEP and KO.
Also impacting aesthetics companies like RVNC imo—the narrative being that people would rather use their money for weight loss copays or self-pay than toxins.
This is what capitulation looks like.
Can you clarify what you mean by "IMHO" with regards to this. Is this your opinion or confirmed by RVNC sales reps? Thanks!
[OT] Classic iHub interface no longer shows thumbs up on the post list page. With the switch to support for universal emoji tagging of posts you can now see these tags in classic view on the post itself, or from the list of posts in the "Full View" beta interface. I'm disappointed because I still prefer Classic view but do find it helpful to see from the post list page which posts have garnered thumbs up (which is itself still a new feature here).
Bio_pete, please see message number 4651 on this board.
Emannow, check out this practice I shared a FB post from earlier. They openly advertise their Daxxify unit price on their website. Hopefully this post doesn't get them in trouble with their sales rep!
If your sales contract says you can't advertise price then in theory Revance could sue you. More likely is they would just stop selling to you. Most likely is that they do absolutely nothing about it.
https://www.jmarieskinstudio.com/injectables
Let's make this clear once and for all.
I've previously accused you of spreading FUD. Perhaps I was wrong about that, I'd need to go back over the old messages and I don't care to do that and nobody here cares anyway.
CosmeticMD, who you seemed to have previously aligned yourself with, just had his reputation implode when I caught him lying dead to rights. I invite everybody here to go back through CosmeticMD's past posts and see how detailed and specific his disinformation was.
If I was wrong about you boraborak38, I apologize. If you're not in fact spreading FUD then you have nothing to worry about from me. Let's not be naïve though. It's now clear as day to anybody who doesn't have their head in the sand that the FUD attacks are vicious and very real. CosmeticMD won't be the last.
I appreciate the tidbits you shared from your sales reps, thank you!
Respectfully I disagree. Even the most seasoned investors can be foiled by FUD in times of stress. All companies are subject to it yes but few to the degree of RVNC. Dr. Blackledge said on investor day he's never seen attacks like the ones against RVNC. Taken with a grain of salt of course, but in combination with what I've witnessed here recently, the attacks are not to be dismissed lightly. There's less we can do from here to fight the disinformation that's being passed to unknowing customers, but that's also an important part of the story obviously. I am not trying to harp on FUD and drown out other conversations. I am actively working on collecting data about Daxxify from multiple channels and will share any useful discoveries with the board if and when I find them.
Let's put it this way...
Before CosmeticMD was proven to be a liar I was 90% sure the statements he was making about Daxxify were false. Now I'm 100% sure. Even for a steadfast bull such as myself, in the face of an enormous share price collapse, that extra 10% of certainty is priceless.
I'd bet there are other people here who feel similarly.
I respect you Joe, but you're a bit unstable emotionally sometimes. You were right about Foley and Dustin, and I was wrong, so credit where it's due. But you are wrong if you're saying FUD doesn't have an impact on the stock price and you're wrong to say I'm "gaslighting" anybody. The disruption of useful information is due to the liars—not me. End of story.
I don't disagree but you're also forgetting the broader market picture. Other biotechs and small caps are trading for negative EV. We are in a deep bear market outside of the mega-cap names hiding that reality from the popular indexes. There is no appetite for companies with increasing losses and uncertain prospects when you can earn 5.5% on ultra short duration money market funds. Eventually the rate hiking cycle will be over and market sentiment will turn. That should allow companies like RVNC to trade at much better multiples.
Looking back at the FUD attack from now proven liar CosmeticMD, it definitely is clear that many will fight tooth and nail to resist Daxxify even though it is the superior product. Of course I was not surprised by the FUD, but discovering who CosmeticMD actually is and seeing how somebody like that could be behind such a vicious smear campaign against RVNC was a bit eye opening. We also know now that this private TBCD FB group exists where FUD is spreading unchecked. There will be more upcoming waves of disinformation on this board most certainly.
RVNC has a difficult battle ahead for sure and management needs to be more focused and not make assumptions like Dew has done.
Thank you, I appreciate that!
Your opinion that he is legitimately on the FB group is helpful. I am 99% sure that he is Dr. Justin Piasecki, a board certified dermatologist—so it checks out that he would be on there. Dew was incorrect that he's not a doctor.
I have no desire to escalate this so I'm looking forward to moving on as well. My desire is to protect this board and RVNC shareholders from liars spreading disinformation about Daxxify.
Looking back now, while CosmeticMD was sloppy and thus ultimately easy to discredit, his lies about Daxxify were extremely specific and detailed. That is exactly how FUD works: they don't have to convince people that they're right, they just have to instill enough doubt to make you unsure.
Thank you Dennboy, much appreciated!
Now that the CosmeticMD account has been completely and fully discredited, I won't be surprised if Dr. Piasecki creates a new account and identity here to spread more FUD about Daxxify.
Ultimately it doesn't matter to RVNC shareholders who is behind the FUD accounts and I expect we will see more new accounts here in coming weeks and months. But it does matter that they are discredited to show everybody that their statements about Daxxify are also lies. CosmeticMD was admittedly extremely sloppy which made it easy to discredit him. Next time might not be as easy.
Really? How about some thanks for discrediting a liar spreading FUD on this board. You guys would rather just sit around and let shorts and shills control the narrative?? That is exactly the FUD game plan: control the narrative and scare people away from trying the new and improved competition. With all due respect to Dew, I think he's underestimated how much the FUD has impacted this stock and how much real long-term negative impact to shareholder value it can have.
https://en.wikipedia.org/wiki/Fear,_uncertainty,_and_doubt
Anybody who says a week ago they never shorted the stock and then this week suddenly they made 600%—no make it 400% with a perfectly time short—is obviously a liar.
This guy is actually no dummy. He went to Stanford. But he is a liar.
I will move on if CosmeticMD disappears, however, since he has now been proven to be a liar, if he continues to spread lies here I will continue to discredit him.